The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 02, 2021
Filed:
Apr. 08, 2014
Applicant:
Berg Llc, Framingham, MA (US);
Inventors:
Niven Rajin Narain, Cambridge, MA (US);
Rangaprasad Sarangarajan, Boylston, MA (US);
Assignee:
Berg LLC, Framingham, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/122 (2006.01); A61K 45/06 (2006.01); A61K 31/7068 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2019.01); C07K 16/32 (2006.01); A61K 31/513 (2006.01); A61K 39/395 (2006.01); A61K 31/4745 (2006.01);
U.S. Cl.
CPC ...
A61K 31/122 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01); A61K 33/24 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/32 (2013.01);
Abstract
Presented herein are methods for the treatment of oncological disorders by the co-administration of CoQ10 formulations and chemotherapeutic agents and/or surgery. The CoQ10 formulations may be at least one of intravenous, topical, or by inhalation. The chemotherapeutic agents may be at least one of antimetabolites or anthracyclines. Co-administration of the CoQ10 formulations may be prior to, concurrent or substantially concurrent with, intermittent with or subsequent to the administration of the chemotherapy.